mounjaro vs zepbound access is a mess

Company: Eli Lilly

Posted by TirzepatideRep_MW_6634 · March 14, 2026

Tags: field, quota, strategy

same mechanism.

different prior auth.

different formulary tier.

different payer criteria.

same patient population.

home office calls it a messaging problem.

its a structural access problem.

losing real scripts over it.

11 upvotes · 5 comments

More from Eli Lilly